Pitfalls and Common Findings in


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
06 2022
Historique:
received: 01 07 2021
revised: 20 08 2021
pubmed: 9 10 2021
medline: 7 6 2022
entrez: 8 10 2021
Statut: ppublish

Résumé

Fibroblast activation protein inhibitor (FAPI) PET/CT is a new tool in the diagnostic workup of cancer. With a growing volume of applications, pitfalls and common findings need to be considered for

Identifiants

pubmed: 34620730
pii: jnumed.121.262808
doi: 10.2967/jnumed.121.262808
pmc: PMC9157730
doi:

Substances chimiques

Gallium Radioisotopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

890-896

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

J Mol Cell Cardiol. 2015 Oct;87:194-203
pubmed: 26319660
Front Biosci. 2008 Jan 01;13:3168-80
pubmed: 17981786
Proc Natl Acad Sci U S A. 1988 May;85(9):3110-4
pubmed: 2896356
Clin Nucl Med. 2020 Dec;45(12):1020-1022
pubmed: 33086274
Clin Nucl Med. 2021 Jul 1;46(7):601-602
pubmed: 33782317
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2117-2136
pubmed: 28765998
Clin Nucl Med. 2021 Jun 1;46(6):520-522
pubmed: 33661208
Arthritis Res Ther. 2006;8(1):R23
pubmed: 16507127
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2059-2061
pubmed: 33543324
J Nucl Med. 2019 Oct;60(10):1421-1429
pubmed: 30850501
Int J Dev Biol. 2001 Apr;45(2):445-7
pubmed: 11330865
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
J Nucl Med. 2019 Dec;60(12):1743-1749
pubmed: 31405922
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Clin Nucl Med. 2021 Aug 1;46(8):700-702
pubmed: 33826575
Ann Rheum Dis. 2020 Nov;79(11):1485-1491
pubmed: 32719042
Clin Transl Med. 2015 Feb 07;4:1
pubmed: 25852817
Clin Nucl Med. 2021 Oct 1;46(10):807-813
pubmed: 34477601
J Nucl Med. 2018 Sep;59(9):1406-1411
pubmed: 29371407
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Nucl Med. 2022 Jan;63(1):89-95
pubmed: 33931468
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1593-1603
pubmed: 33097975
J Nucl Med. 2021 Jun 1;62(6):779-786
pubmed: 33097632
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4089-4100
pubmed: 34050777
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3221-3227
pubmed: 33620560
Eur Heart J. 2011 Nov;32(21):2713-22
pubmed: 21292680
Clin Nucl Med. 2021 Aug 1;46(8):e433-e435
pubmed: 33782295
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):196-203
pubmed: 32468254
Clin Nucl Med. 2021 Aug 1;46(8):683-685
pubmed: 33826569
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Mol Oncol. 2016 Jan;10(1):40-58
pubmed: 26304112
Int Rev Cell Mol Biol. 2012;297:83-116
pubmed: 22608558
J Am Coll Cardiol. 2021 Apr 13;77(14):1835-1837
pubmed: 33832609
PLoS One. 2015 Mar 16;10(3):e0116683
pubmed: 25775399

Auteurs

Lukas Kessler (L)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; lukas.kessler@uk-essen.de.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Justin Ferdinandus (J)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Nader Hirmas (N)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Fadi Zarrad (F)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Michael Nader (M)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

David Kersting (D)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Manuel Weber (M)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Sandra Kazek (S)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Miriam Sraieb (M)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Rainer Hamacher (R)

German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; and.

Katharina Lueckerath (K)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Lale Umutlu (L)

German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Institute of Diagnostic and Interventional Radiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Wolfgang P Fendler (WP)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Christoph Rischpler (C)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH